BIOCARDIA, INC. (BCDA) Return on equity 2016–2025
BIOCARDIA, INC. (BCDA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-919.3%FY2025 · since FY2016: -50.1% → -919.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -919.3% | +30.0 pp |
| FY2024 | -949.3% | — |
| FY2022 | -243.4% | -121.7 pp |
| FY2021 | -121.7% | -43.4 pp |
| FY2020 | -78.2% | +542.4 pp |
| FY2019 | -620.6% | -251.8 pp |
| FY2018 | -368.9% | -258.2 pp |
| FY2017 | -110.6% | -60.5 pp |
| FY2016 | -50.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice